Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Open accessAbstract
The interplay between mitochondrial energetics, lipid balance, and muscle insulin sensitivity has remained a topic of intense interest and debate for decades. One popular view suggests that increased oxidative capacity benefits metabolic wellness, based on the premise that it is healthier to burn fat than glucose. Attempts to test this hypothesis using genetically modified mouse models have produced contradictory results and instead link muscle insulin resistance to excessive fat oxidation, acylcarnitine production, and increased mitochondrial H(2)O(2)-emitting potential. Here, we consider emerging evidence that insulin action in muscle is driven principally by mitochondrial load and redox signaling rather than oxidative capacity.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 143 cited sources checked · 0 supported · 0 flagged
- Premisecitation
The same allosteric effectors activate pyruvate dehydrogenase kinases, which phosphorylate pyruvate dehydrogenase and further inhibit its catalytic activity.
“This same set of allosteric effectors activates a family of pyruvate dehydrogenase kinases that phosphorylate PDH, further inhibiting the catalytic activity of the enzyme (Sugden and Holness, 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sugden and Holness, 2006
Not checked in the free run.
- Premisecitation
Intramyocellular lipid content is a strong predictor of insulin resistance.
“Subsequent studies identified intramyocellular lipid content as a strong predictor of insulin resistance.”
Quote in the paperSubstantial claim - Premisecitation
A caveat of these and similar animal studies is that their methods did not account for label dilution from hydrolysis and catabolism of endogenous lipids, which are more abundant in obesity.
“A notable caveat of these and several similar animal studies is that the methods used did not account for potential label dilution effects due to hydrolysis and catabolism of endogenously-derived lipids, which are more abundant in the obese state (Boyle et al., 2011; Thyfault et al., 2010).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Intramuscular and/or hepatic content of triacylglycerol, diacylglycerol, and/or ceramide correlates negatively with insulin sensitivity.
“Support for this model grew from numerous reports showing that intramuscular and/or hepatic content of triacylglycerol, diacylglycerol and/or ceramide correlate negatively with insulin sensitivity (Erion and Shulman, 2010; Goodpaster and Kelley, 2002; Holland and Summers, 2008).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Erion and Shulman, 2010
Not checked in the free run.
- cites Goodpaster and Kelley, 2002 source
Not checked in the free run.
- cites Holland and Summers, 2008
Not checked in the free run.
- Premisecitation
The negative relationship between lipid content and insulin sensitivity is evident in obese and diabetic humans and in several rodent and cell culture models of metabolic disease and/or chronic lipid exposure.
“This relationship is evident in obese and diabetic humans as well as in several rodent and cell culture models of metabolic disease and/or chronic lipid exposure (An et al., 2004; Hulver et al., 2003; Nagle et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checked
- Premisecitation
Insulin sensitivity correlates positively with skeletal muscle oxidative potential assessed by enzyme activities and genome-wide expression arrays.
“Nonetheless, investigators found that insulin sensitivity correlated positively with skeletal muscle oxidative potential, assessed by enzyme activities as well as genome-wide expression arrays (Patti et al., 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Patti et al., 2003 source
Not checked in the free run.
- Premisecitation
In type 2 diabetic subjects, glucose uptake rather than glucose phosphorylation is the rate-limiting barrier for muscle glucose disposal.
“Using stable isotopes and NMR methodology these studies pointed to glucose uptake rather than glucose phosphorylation as the rate-limiting barrier for muscle glucose disposal in type 2 diabetic subjects (Shulman, 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shulman, 2000 source
Not checked in the free run.
- Interpretationcitation
A decline in skeletal muscle mitochondrial density due to disease or aging could decrease overall basal metabolic rate and energy requirements.
“a decline in mitochondrial density in skeletal muscle due to disease or aging could decrease overall basal metabolic rate and thus energy requirements (Brand, 1990).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brand, 1990 source
Not checked in the free run.
- Interpretationreasoning
Regardless of mitochondrial oxidative capacity, intracellular lipids accumulate whenever fatty acid supply exceeds cellular energy needs.
“Thus, regardless of mitochondrial oxidative capacity, intracellular lipids amass whenever the supply of fatty acids exceeds the energy needs of the cell.”
Quote in the paperSubstantial claim- Rests on an assumption: Intracellular lipids accumulate whenever fatty acid supply exceeds cellular energy needs.
- Interpretationreasoning
Several lines of evidence do not support mitochondrial dysfunction as a root cause of lipotoxicity and insulin resistance.
“Several lines of evidence however do not support the idea that mitochondrial dysfunction is a root cause of lipotoxicity and insulin resistance.”
Quote in the paperSubstantial claim - Interpretationreasoning
Loss of mitochondrial integrity is likely to compromise exercise tolerance.
“This loss of mitochondrial integrity is likely to compromise exercise tolerance.”
Quote in the paperNot a substantial claim - Premisecitation
An estimated 10-25% of resting metabolic rate is attributed to respiration supporting mitochondrial proton leak.
“Moreover, because an estimated 10–25% of resting metabolic rate is attributed to respiration that supports mitochondrial proton leak (i.e., “idling”) (Rolfe and Brown, 1997), and because skeletal muscle represents a high percentage of body mass, a decline in mitochondrial density in skeletal muscle due to disease or aging could decrease overall basal metabolic rate and thus energy requirements (”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rolfe and Brown, 1997 source
Not checked in the free run.
- Premisecitation
Electron microscopy of skeletal muscle from mice on prolonged high fat diet shows profound mitochondrial changes including swelling and disarrayed cristae.
“Electron microscopy images of skeletal muscle from mice on a prolonged high fat diet reveal profound changes in the appearance of mitochondria, including visible swelling and disarrayed cristae (Bonnard et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bonnard et al., 2008
Not checked in the free run.
- Interpretationreasoning
Despite adaptations favoring fat catabolism, ectopic lipids still accumulate because supply outpaces demand.
“Despite adaptations that favor fat catabolism, ectopic lipids still accumulate because supply outpaces demand.”
Quote in the paperSubstantial claim- Rests on an assumption: Intracellular lipids accumulate whenever fatty acid supply exceeds cellular energy needs.
- Interpretationreasoning
Individual differences in muscle mitochondrial content and β-oxidation enzyme activities should have little bearing on intramuscular lipid accumulation because oxidative phosphorylation rarely operates at maximal capacity.
“Similarly, individual differences in muscle mitochondrial content and the specific activities of β-oxidation enzymes should have little bearing on intramuscular lipid accumulation because oxidative phosphorylation is rarely operating at maximal capacity.”
Quote in the paperSubstantial claim- Rests on an assumption: Oxidative phosphorylation is rarely operating at maximal capacity.
- Interpretationcitation
Emerging evidence suggests that during initial overnutrition and insulin resistance, carbon load on muscle oxidative machinery mounts such that fatty acid catabolism persistently exceeds ATP resynthesis demand.
“Emerging evidence suggests that the carbon load on the muscle’s oxidative machinery begins to mount, such that the rate of fatty acid catabolism persistently surpasses the drive for ATP resynthesis.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Mitochondrial oxidative capacity declines only after several months on a high fat diet.
“It is only after several months on a high fat diet that mitochondrial oxidative capacity declines (Bonnard et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bonnard et al., 2008
Not checked in the free run.
- Interpretationreasoning
Even obese and/or diabetic individuals have enough mitochondrial reserve to substantially increase substrate flux and ATP synthesis for light to moderate contractile activity.
“In general, even obese and/or diabetic individuals have enough mitochondrial reserve to substantially increase substrate flux and ATP synthesis to meet the energy demands of light to moderate contractile activity.”
Quote in the paperSubstantial claim - Premisecitation
Similar abnormalities in acylcarnitine accumulation and incomplete β-oxidation occur in humans with obesity or type 2 diabetes and in primary human skeletal myocytes from obese compared to lean subjects.
“Similar abnormalities in acylcarnitine accumulation and incomplete β-oxidation have been identified in humans with obesity or type 2 diabetes (Adams et al., 2009; Huffman et al., 2009; Mihalik et al., 2010) and in primary human skeletal myocytes derived from obese compared to lean subjects (Bell et al., 2010; Kovalik et al., 2011).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationcitation
Simply shifting substrate selection toward fat oxidation does not protect against diet-induced insulin resistance when whole-body energy balance is unchanged.
“Taken together, these findings suggest that simply shifting substrate selection in favor of fat oxidation does not protect against diet-induced insulin resistance when whole body energy balance is unchanged.”
Quote in the paperSubstantial claim - Premisecitation
Overexpression of CPT-1 in cultured myocytes or rat skeletal muscles using recombinant adenovirus or electroporation enhances insulin-stimulated glucose uptake.
“Conversely, overexpression of CPT-1 in cultured myocytes or rat skeletal muscles using recombinant adenovirus or electroporation techniques has been shown to enhance insulin-stimulated glucose uptake (Bruce et al., 2009; Henique et al., 2010; Perdomo et al., 2004; Sebastian et al., 2007).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Synthetic agonists of PPARα and PPARβ/δ ameliorate lipid-induced insulin resistance in C2C12 cells and obese rodents.
“Administration of synthetic agonists of PPARα and PPARβ/δ have been shown to ameliorate lipid-induced insulin resistance in C2C12 cells and obese rodents (Coll et al., 2010; Guerre-Millo et al., 2000; Kramer et al., 2005; Tanaka et al., 2003).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
In second-generation ACC2 models, total energy expenditure was either unaffected or only slightly increased.
“In these second generation models total energy expenditure was either unaffected (Hoehn et al., 2010) or only slightly increased (Olson et al., 2010).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
When insulin sensitivity is assessed by euglycemic clamp, some studies report improvements after etomoxir treatment while others find the opposite.
“However, when insulin sensitivity was assessed by the euglycemic clamp technique, some studies reported improvements after etomoxir treatment whereas others found the opposite effect (Dobbins et al., 2001; Hubinger et al., 1997).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Conditional deletion of CrAT in mice confirmed that this enzyme is essential for defending whole-body glucose homeostasis.
“Ensuing studies in mice with conditional deletion of CrAT confirmed an essential role for this enzyme in defending whole body glucose homeostasis (Muoio et al., (in press)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Muoio et al., (in press)
Not checked in the free run.
- Premisecitation
Muscle-specific ablation of CrAT results in systemic glucose intolerance.
“muscle-specific ablation of CrAT resulted in systemic glucose intolerance”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Muoio et al., (in press)
Not checked in the free run.
- Interpretationreasoning
The opposite responses to pharmacological and genetic activation of the same gene probably relate to cellular bioenergetics.
“Why do pharmacological and genetic activation of the same gene induce opposite responses? The answer probably relates to cellular bioenergetics.”
Quote in the paperSubstantial claim - Premisecitation
Muscle-specific transgenic overexpression of PPARα or PGC-1α, despite upregulating oxidative enzymes and enhancing fat oxidation capacity, makes mice more susceptible to diet-induced insulin resistance.
“However, despite impressive upregulation of several oxidative enzymes and markedly enhanced capacity for fat oxidation in muscle, both of these transgenic mouse models were more susceptible to diet-induced insulin resistance (Choi et al., 2008; Finck et al., 2005).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationcitation
Muscle accumulation of acylcarnitines and pyruvate in insulin-resistant states is consistent with increased mitochondrial acyl-CoA levels imposing negative feedback on PDH.
“Muscle accumulation of acylcarnitines and pyruvate observed in insulin resistant states (Boyle et al., 2011; Thyfault et al., 2010) is consistent with an increase in mitochondrial acyl CoA levels that impose negative feedback on PDH.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Boyle et al., 2011 source
Not checked in the free run.
- cites Thyfault et al., 2010 source
Not checked in the free run.
- Rests on an assumption: Acylcarnitines are generally viewed as byproducts of mitochondrial metabolism that report on cellular fluctuations in substrate supply and flux limitations at specific catabolic enzymes.
- Premisecitation
In L-carnitine studies, improvements in whole-body and mitochondrial metabolic function corresponded with robust increases in plasma and urinary acetylcarnitine.
“In these studies, improvements in metabolic function at the whole body and mitochondrial level corresponded with robust increases in plasma and urinary concentrations of acetylcarnitine (Noland et al., 2009), a metabolite that is produced from acetyl CoA and carnitine by the mitochondrial matrix enzyme carnitine acetyltransferase (CrAT).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Noland et al., 2009 source
Not checked in the free run.
- Premisecitation
Similar findings on metabolic inflexibility emerged from subsequent studies in humans and rodents.
“Similar findings emerged from several subsequent studies in both humans and rodents (Koves et al., 2008; van Herpen et al., 2011).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Nutrient-induced substrate switching is often compromised in obesity and type 2 diabetes.
“In recent years it has become increasingly apparent that nutrient-induced substrate switching is often compromised in the settings of obesity and type 2 diabetes (Kelley and Mandarino, 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kelley and Mandarino, 2000 source
Not checked in the free run.
- Premisecitation
In cultured L6 myotubes, the repressive effects of PPARα overexpression on glucose uptake are reversed by dinitrophenol, a protonophore that increases energy demand by raising proton conductance of the mitochondrial inner membrane.
“In cultured L6 myotubes, the repressive effects of PPARα overexpression on glucose uptake are reversed by addition of dinitrophenol (Finck et al., 2005), a protonophore that elevates energy demand by increasing proton conductance of the mitochondrial inner membrane.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Finck et al., 2005 source
Not checked in the free run.
- Premisecitation
Muscle-specific ablation of CrAT results in complete loss of carnitine-stimulated PDH activity.
“complete loss of carnitine-stimulated PDH activity”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Muoio et al., (in press)
Not checked in the free run.
- Interpretationreasoning
Co-localization of MondoA and hexokinase at the mitochondrial membrane reflects a mechanism that couples mitochondrial sensing of glycolytic flux to cellular glucose transport.
“Taken together, these provocative new findings imply that co-localization of MondoA and hexokinase at the mitochondrial membrane reflects a mechanism that couples mitochondrial sensing of glycolytic flux to cellular glucose transport.”
Quote in the paperNot a substantial claim- Rests on an assumption: In skeletal muscle, TXNIP gene expression is controlled by MondoA.
- Premisecitation
The translocation of MondoA:MLX to the nucleus requires hexokinase activity.
“an event that requires hexokinase activity (Stoltzman et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stoltzman et al., 2008 source
Not checked in the free run.
- Premisecitation
Acylcarnitines function in a homeostatic capacity to relieve mitochondrial stress.
“the weight of evidence at this stage suggests that these metabolites function in a homeostatic capacity to relieve mitochondrial stress (Figure 1) (Muoio et al., (in press), Mingorance et al., 2011; Noland et al., 2009; Power et al., 2007).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Muoio et al., (in press)
Not checked in the free run.
- cites Mingorance et al., 2011
Not checked in the free run.
- cites Noland et al., 2009 source
Not checked in the free run.
- Premisecitation
MondoA:MLX complexes are latently held at the outer mitochondrial membrane and translocate to the nucleus when glycolytic intermediates accumulate.
“MondoA:MLX complexes are latently held at the outer mitochondrial membrane and translocate to the nucleus when glycolytic intermediates accumulate (Sloan and Ayer, 2010)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sloan and Ayer, 2010
Not checked in the free run.
- Premisecitation
Insulin resistant states are associated with decreased tissue levels of reduced relative to oxidized glutathione (GSH:GSSG).
“decreased tissue levels of reduced relative to oxidized glutathione (GSH:GSSG), a well-established biomarker of oxidative/reductive stress.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Anderson et al., 2009 source
Not checked in the free run.
- Premisecitation
Genetic or pharmacological manipulations that lower mitochondrial ROS production preserve insulin action in lipid-treated myotubes and in mice fed a high-fat diet.
“genetic or pharmacological manipulations that lowered mitochondrial ROS production preserved insulin action in lipid-treated myotubes (Hoehn et al., 2009) and in mice fed a high fat diet (Anderson et al., 2009; Hoehn et al., 2009; Lee et al., 2010).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
ROS are bona fide signaling molecules.
“ROS are now viewed as bona fide signaling molecules”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Treatment of genetically obese/diabetic rodents with antioxidant nutrients improves insulin action and glucose homeostasis.
“Treatment of genetically obese/diabetic rodents with antioxidant nutrients has been shown to improve insulin action and glucose homeostasis (Henriksen, 2006; Hoehn et al., 2009; Houstis et al., 2006).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationcitation
Chronic elevations in incomplete oxidation of fatty acids and branched chain amino acids might foster a mitochondrial microenvironment conducive to ROS production.
“Thus, chronic elevations in incomplete oxidation of fatty acids and branched chain amino acids (Newgard, 2012) might foster a mitochondrial microenvironment that is conducive to ROS production.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Newgard, 2012 source
Not checked in the free run.
- Premisecitation
Oxidant stress activates serine kinases and transcription factors linked to insulin resistance, including JNK, IKK-β, NF-kB, and PKC.
“oxidant stress is known to activate several of the serine kinases and transcription factors that have been linked to insulin resistance, including c-jun amino-terminal kinases (JNK), IkB kinase catalytic subunit β (IKK-β), NF-kappa B transcription factor (NF-kB) and protein kinase C (PKC) (Bloch-Damti and Bashan, 2005; Chakraborti and Chakraborti, 1998)).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Insulin resistant states are associated with increased H2O2 emission from muscle mitochondria.
“insulin resistant states were associated with increased H2O2 emission from muscle mitochondria”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Anderson et al., 2009 source
Not checked in the free run.
- Premisecitation
Insulin resistance is linked to mitochondrial H2O2 emission.
“A subsequent report provided compelling evidence linking insulin resistance to mitochondrial H2O2 emission (Anderson et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Anderson et al., 2009 source
Not checked in the free run.
- Interpretationreasoning
Any change in the rate of substrate oxidation must be considered in the context of energy demand.
“any change in the rate of substrate oxidation must be considered in the context of energy demand.”
Quote in the paperSubstantial claim- Rests on an assumption: Cellular and mitochondrial bioenergetics is governed by the rate of energy expenditure.
- Interpretationreasoning
Mitochondrial accumulation of various short chain acyl-CoAs could trigger broad-ranging metabolic consequences via their impact on protein modifications.
“implying that mitochondrial accumulation of various short chain acyl-CoAs could trigger broad-ranging metabolic consequences via their impact on protein modifications.”
Quote in the paperSubstantial claim - Premisecitation
Sirt3 knockout mice develop multiple elements of the metabolic syndrome with aging.
“These animals also develop multiple elements of the metabolic syndrome with aging (Hirschey et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hirschey et al., 2011 source
Not checked in the free run.
- Interpretationreasoning
The flux rate through β-oxidation relative to energy demand is a particularly important determinant of insulin sensitivity in skeletal muscle.
“the flux rate through β-oxidation relative to energy demand appears to be a particularly important determinant of insulin sensitivity in skeletal muscle.”
Quote in the paperSubstantial claim - Premisecitation
Elevated energy expenditure can arise only from increased thermogenesis, heavier reliance on inefficient ATP regenerating systems, enhanced carbon flux through futile energetic cycles, or increased physical/locomotor activity.
“Elevated energy expenditure can arise only from an increase in thermogenesis (i.e., uncoupling), heavier reliance on inefficient ATP regenerating systems, enhanced carbon flux through futile energetic cycles, or increased physical/locomotor activity (Butler and Kozak, 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Butler and Kozak, 2010
Not checked in the free run.
- Premisecitation
AMPK functions as a critical cellular sensor of energy deficit that triggers a multifaceted cascade of catabolic responses at the levels of cell signaling, metabolism, and transcriptional control.
“AMPK functions as a critical cellular sensor of energy deficit that in turn triggers a multifaceted cascade of catabolic responses at the levels of cell signaling, metabolism and transcriptional control (Kahn et al., 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kahn et al., 2005 source
Not checked in the free run.
- Interpretationcitation
Activation of AMPK in these models suggests that the maneuvers first elicited a negative energy balance in the affected tissues.
“its activation offers a strong hint that the maneuvers under consideration first elicited a negative energy balance in the affected tissues.”
Quote in the paperNot a substantial claim- Rests on an assumption: Many of the same genetic manipulations result in activation of AMPK.
- Premisecitation
Fuel metabolism and overnutrition are linked to changes in the acylation state of mitochondrial proteins.
“recent studies linking fuel metabolism and overnutrition to changes in the acylation state of mitochondrial proteins (Hirschey et al., 2009; Huang et al., 2010).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
Increased energy expenditure is the common underlying mechanism accounting for the lean, insulin-sensitive phenotype in these transgenic models.
“These findings suggest that increased energy expenditure is the common underlying mechanism accounting for the lean, insulin-sensitive phenotype.”
Quote in the paperSubstantial claim- Rests on an assumption: Nearly all transgenic mouse models resistant to high-fat diet-induced obesity and insulin resistance have elevated whole-body VO2 with similar or even greater food intake relative to wildtype littermates.
- Premisecitation
Sirt4 and sirt5 regulate protein malonylation and succinylation.
“recent studies have revealed novel roles for sirt4 and sirt5 in regulating protein malonylation and succinylation (Du et al., 2011; Peng et al., 2011; Zhang et al., 2011)”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationreasoning
The increased energy expenditure evident in many mouse models that resist diet-induced metabolic abnormalities could represent the common underlying protective mechanism.
“the increased energy expenditure evident in many of the mouse models that resist diet-induced metabolic abnormalities could represent the common underlying protective mechanism.”
Quote in the paperSubstantial claim - Premisecitation
A remarkable number of transgenic mouse models are resistant to high-fat diet-induced obesity and insulin resistance.
“a remarkable number of transgenic mouse models are resistant to high fat diet-induced obesity and insulin resistance (Chen and Farese, 2001; Reitman, 2002).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Chen and Farese, 2001
Not checked in the free run.
- cites Reitman, 2002 source
Not checked in the free run.
- Interpretationnone given
A small increase in energy demand completely relieves the reducing pressure and ROS production in mitochondria created by a positive energy balance.
“even a small increase in energy demand will completely relieve the reducing pressure and ROS production in mitochondria created by a positive energy balance”
Quote in the paperNot a substantial claim- Rests on an assumption: Cellular and mitochondrial bioenergetics is governed by the rate of energy expenditure.
- Premisecitation
Wildtype animals consuming a high-fat diet manifest a persistent mismatch in mitochondrial lipid load relative to energy demand, resulting in muscle accumulation of partially oxidized fatty acylcarnitine intermediates.
“wildtype animals consuming a high fat diet manifest a persistent mismatch in mitochondrial lipid load relative to energy demand, resulting in muscle accumulation of partially oxidized fatty acylcarnitine intermediates (Koves et al., 2005; Koves et al., 2008)”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Long-term maintenance of lifestyle modifications has proven challenging, evidenced by high recidivism rates.
“long term maintenance of lifestyle modifications has proven challenging, evidenced by disappointingly high recidivism rates (Turk et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Turk et al., 2009 source
Not checked in the free run.
- Interpretationreasoning
The etiology of muscle insulin resistance is grounded in the fundamental principles that govern cellular and mitochondrial bioenergetics, and the redox pressures placed on the respiratory system when energy supply persistently outpaces energy demand.
“we suggest that the etiology of muscle insulin resistance is grounded in the fundamental principles that govern cellular and mitochondrial bioenergetics, and the redox pressures that are placed on the respiratory system when energy supply persistently outpaces energy demand (Figure 2).”
Quote in the paperSubstantial claim - Interpretationreasoning
Mitochondrial adaptations that benefit exercise performance favor energy efficiency and glucose sparing.
“mitochondrial adaptations that benefit exercise performance are those that favor energy efficiency and glucose sparing”
Quote in the paperSubstantial claim - Premisecitation
Mice genetically engineered to have restricted flux through β-oxidation in muscle maintain normal insulin sensitivity on a high-fat diet even though lipid content of muscle, liver and/or adipose tissue remains elevated.
“mice that were genetically-engineered to have restricted flux through β-oxidation in muscle maintain normal insulin sensitivity on a high fat diet even though lipid content of muscle, liver and/or adipose tissue remain elevated (Finck et al., 2005; Guerre-Millo et al., 2001; Koves et al., 2008; Tordjman et al., 2001).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationnone given
Evidence disputes the prediction that lifestyle-related insulin resistance in muscle is caused by sluggish mitochondria with inherent deficits in fat oxidation.
“We highlighted a new wave of evidence in dispute of the simple prediction that lifestyle-related insulin resistance in muscle is caused by sluggish mitochondria with inherent deficits in fat oxidation.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 15
- May combine two claims. 44
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe glucose-fatty acid cycle model proposes that increased fatty acid supply and oxidation cause cellular accumulation of acetyl-CoA, NADH, and ATP, which allosterically inhibit pyruvate dehydrogenase.
“The model was developed based on the finding that increasing the supply and oxidation of fatty acids leads to cellular accumulation of acetyl-CoA, NADH and ATP, which allosterically inhibit pyruvate dehydrogenase (PDH), the mitochondrial enzyme complex that couples glycolysis to glucose oxidation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Randle et al., 1963 source
Not checked in the free run.
May combine two claims.
Interpretationnone givenTests of whether greater oxidative capacity improves metabolic health in genetically modified mice have given conflicting results and instead associate muscle insulin resistance with excessive fat oxidation, acylcarnitine production, and higher mitochondrial H2O2 emission potential.
“Attempts to test this hypothesis using genetically-modified mouse models have produced contradictory results; and instead link muscle insulin resistance to excessive fat oxidation, acylcarnitine production and increased mitochondrial H2O2 emitting potential.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHuman studies suggest that skeletal muscle fat oxidation capacity is lower in obese than lean subjects, with mitochondrial insufficiencies most pronounced in severe obesity and/or diabetes.
“Human studies that measured whole body substrate selection by indirect calorimetry, fatty acid flux across the leg, fatty acid oxidation in isolated skeletal muscle strips and/or maximal activities of various oxidative enzymes in biopsy specimens, strongly suggested that skeletal muscle capacity to oxidize fat is lower in obese compared to lean subjects; with the apparent mitochondrial insufficien”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRandle proposed that a rise in cellular citrate inhibits phosphofructokinase-1, and that reduced glycolysis and pyruvate oxidation cause glucose-6-phosphate accumulation, allosteric hexokinase inhibition, and diminished glucose uptake.
“Randle further proposed that a rise in cellular citrate would inhibit phosphofructokinase-1 (Denton and Randle, 1966), and that lowering of glycolysis and pyruvate oxidation would result in accumulation of glucose-6-phosphate, leading to allosteric inhibition of hexokinase and thus diminished glucose uptake.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Denton and Randle, 1966
Not checked in the free run.
May combine two claims.
PremisereasoningLipid-induced insulin resistance is not due to inhibition of glycolysis and glucose oxidation but instead stems from accumulation of lipid signaling molecules such as diacylglycerol and ceramide that disrupt insulin-stimulated GLUT4 translocation.
“Together, these observations led to the conclusion that lipid-induced insulin resistance is not due to inhibition of glycolysis and glucose oxidation, but instead stems from a more direct and proximal mechanism wherein tissue accumulation of lipid signaling molecules such as diacylglycerol and ceramide disrupt insulin-stimulated translocation of the GLUT4 glucose transporter.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThese findings suggest that during diet-induced obesity/diabetes etiology, mitochondrial architecture deteriorates, ultimately leading to mitophagy and complete organelle dissolution.
“These findings suggest that at some point in the etiology of diet-induced obesity/diabetes, mitochondrial architecture begins to deteriorate, ultimately leading to mitophagy and the complete dissolution of the organelle (Mitsuhashi et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mitsuhashi et al., 2011 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningLower resting substrate flux and/or ATP synthesis should not be interpreted as mitochondrial dysfunction or blamed for local lipid metabolite accumulation.
“Lower rates of substrate flux and/or ATP synthesis measured at rest should not be interpreted as evidence of mitochondrial dysfunction nor blamed for local accumulation of lipid metabolites.”
Quote in the paperSubstantial claim- Rests on an assumption: Mitochondrial respiration in all cells is governed by energy demand, including basal or idling respiratory activity and ATP regeneration.
May combine two claims.
PremisecitationSkeletal muscle from obese humans with or without diabetes has reduced overall mitochondrial content and morphological changes similar to animal models.
“Skeletal muscle from obese humans with or without diabetes is characterized by reduced overall mitochondrial content with evidence of morphological changes similar to those in the animal models (Chomentowski et al., 2011; Kelley et al., 2002; Ritov et al., 2005).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenWithout a corresponding reduction in caloric intake, the probability that fuel supply exceeds demand increases, not because oxidative capacity is diminished but because the costs of maintaining energy balance decrease.
“Without a corresponding reduction in caloric intake, the probability that fuel supply will exceed demand increases, not because of diminished oxidative capacity but because the costs of maintaining energy balance decrease.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMagnetic resonance spectroscopy studies found mitochondrial substrate flux and/or ATP synthesis rates depressed in muscle of elderly insulin-resistant individuals and lean insulin-resistant young subjects with a family history of type 2 diabetes.
“Additional investigations employing non-invasive magnetic resonance spectroscopy (MRS) found that both mitochondrial substrate flux and/or ATP synthesis rates were depressed in muscle of elderly individuals with insulin resistance (Petersen et al., 2003) and in lean, insulin-resistant young subjects with a family history of type 2 diabetes (Petersen et al., 2004).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationThese studies led to the proposal that insulin-resistant humans have faulty muscle mitochondria and intrinsic oxidative metabolism deficiencies that divert fatty acids from oxidation toward diacylglycerols and other toxic lipids, impairing insulin signaling.
“These and other studies led to the proposal that insulin resistant humans have faulty muscle mitochondria and intrinsic deficiencies in oxidative metabolism that impinge on insulin signaling by diverting fatty acids away from oxidation and toward production of diacylglycerols and other toxic lipid species (Lowell and Shulman, 2005; Roden, 2005).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationTransgenic mouse models with targeted disruptions in mitochondrial proteins or master regulators of mitochondrial biogenesis have severely compromised oxidative performance, but many show increased insulin sensitivity relative to wild type, even on a fat-enriched diet.
“As anticipated these mice have severely compromised oxidative performance, but contrary to the predicted development of insulin resistance, many of these transgenic models display increased insulin sensitivity relative to wild type mice, even when challenged with a fat-enriched diet (reviewed in (Muoio, 2010)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Muoio, 2010 source
Not checked in the free run.
May combine two claims.
PremisecitationIn second-generation ACC2 knockout models, the switch to fat catabolism was offset by diminished glucose oxidation and a reciprocal rise in de novo lipogenesis.
“Instead, the genetically engineered switch to fat catabolism was offset by diminished glucose oxidation and a reciprocal rise in de novo lipogenesis.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationEarly stages of diet-induced insulin resistance are characterized by increasing β-oxidation and no change in respiratory capacity.
“In aggregate, the results showed that the early stages of diet-induced insulin resistance are characterized by increasing β-oxidation and no change in respiratory capacity (Hancock et al., 2008; Kraegen et al., 2008; Noland et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationACC2−/− mice have higher whole-body and muscle fatty acid oxidation rates.
“Indeed, ACC2−/− mice proved to have higher whole-body and muscle fatty acid oxidation rates (Abu-Elheiga et al., 2001; Abu-Elheiga et al., 2003).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIn ACC2−/− mice, both fat and carbohydrate oxidation are simultaneously increased, which was credited as the impetus for increased total body energy expenditure without considering changes in energy demand.
“Both fat and carbohydrate oxidation were simultaneously increased in ACC2−/− mice, which was curiously credited as the impetus for increased total body energy expenditure without consideration of potential changes in energy demand (Choi et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Choi et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationACC2 is localized on the outer mitochondrial membrane and catalyzes malonyl-CoA synthesis, which inhibits CPT-1, the gatekeeper for fatty acid entry into mitochondria.
“ACC2 appears to be localized on the outer mitochondrial membrane (Abu-Elheiga et al., 2001) where it catalyzes the synthesis of malonyl-CoA, a potent inhibitor of carnitine palmitoyltransferase-1 (CPT-1); the enzyme that functions as the gatekeeper for fatty acid entry into the mitochondria.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Abu-Elheiga et al., 2001 source
Not checked in the free run.
May combine two claims.
PremisecitationTwo other groups generated whole-body and muscle-specific ACC2 knockout models and found no effect of gene deletion on body weight, food intake, body composition, or susceptibility to diet-induced obesity and glucose intolerance.
“Intriguingly however, two other groups have recently generated whole body- and muscle-specific ACC2 knockout models and found no effect of the gene deletion on body weight, food intake, body composition and susceptibility to diet-induced obesity and glucose intolerance (Hoehn et al., 2010; Olson et al., 2010).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationDiet-induced and genetic insulin resistance are associated with high rates of incomplete fat oxidation, shown by intramuscular accumulation of mitochondrial-derived fatty acylcarnitine intermediates and reduced TCA cycle intermediates.
“This situation first came to light with the discovery that both diet-induced and genetic forms of insulin resistance were associated with high rates of incomplete fat oxidation, evidenced by intramuscular accumulation of several mitochondrial-derived fatty acylcarnitine intermediates and reduced levels of TCA cycle intermediates (Koves et al., 2005; Koves et al., 2008).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationACC2−/− mice are hyperphagic but maintain normal body weight, glycemic control, and muscle insulin sensitivity even on a high fat diet.
“These animals were also hyperphagic but maintained normal body weight, glycemic control and muscle insulin sensitivity, even when fed a high fat diet (Abu-Elheiga et al., 2003; Choi et al., 2007).”
Quote in the paperSubstantial claim0 of 2 sources checkedClassified as probably not a substantial claim. May combine two claims.
PremisecitationPPARs are lipid-activated nuclear receptors that stimulate expression of genes involved in fatty acid transport and oxidation.
“Another approach that is commonly deployed to evaluate the role of mitochondrial fatty acid oxidation in the etiology of insulin resistance centers on exploitation of the peroxisome proliferator-activated receptors (PPAR α, β/δ and ), a family of lipid-activated nuclear receptors that stimulate expression of genes involved in transport and oxidation of fatty acids (Desvergne et al., 1998).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Desvergne et al., 1998 source
Not checked in the free run.
May combine two claims.
PremisecitationIn type 2 diabetic humans and obese rodents, oral CPT-1 inhibitors such as etomoxir and oxfenicine consistently elevate glucose oxidation and ameliorate hyperglycemia and hyperinsulinemia.
“In type 2 diabetic humans and in obese rodents, oral administration of CPT-1 inhibitors such as etomoxir and oxfenicine consistently elevates glucose oxidation and ameliorates hyperglycemia and hyperinsulinemia (Barnett et al., 1992; Deems et al., 1998; Dobbins et al., 2001; Fragasso et al., 2009; Hubinger et al., 1997).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationMassive overexpression of any mitochondrial membrane protein tends to disrupt native stoichiometry and mitochondrial membrane integrity, producing artifactual acceleration in proton conductance and increased energy expenditure.
“Moreover, massive overexpression of any mitochondrial membrane protein tends to disrupt the native stoichiometry and integrity of the mitochondrial membrane, generating an artifactual acceleration in proton conductance and a concomitant increase in energy expenditure (Cadenas et al., 2002; Harper et al., 2002; Henique et al., 2010; Perdomo et al., 2004; Sebastian et al., 2007)”
Quote in the paperSubstantial claim0 of 3 sources checkedClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThe genetic approaches used in CPT-1 overexpression studies yield poor transfection efficiencies, raising the question of whether enhanced insulin action in the whole myocyte/myofiber population was due to events within transfected cells.
“Notably however, the genetic approaches used in these studies yield notoriously poor transfection efficiencies, thereby raising the question of whether enhanced insulin action measured in the entire population of myocytes/myofibers was actually due to events occurring within the transfected cells.”
Quote in the paperSubstantial claim- Rests on an assumption: The genetic approaches used in CPT-1 overexpression studies yield notoriously poor transfection efficiencies.
May combine two claims.
PremisecitationChronic etomoxir administration causes severe hepatic steatosis and heightened oxidative stress.
“Interpretation of these studies is further complicated by the observation that chronic administration of etoxomir causes severe hepatic steatosis, while also provoking a state of heightened oxidative stress (Vickers et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vickers et al., 2006 source
Not checked in the free run.
May combine two claims.
InterpretationcitationPotent inhibition of liver CPT-1 leads to undesirable outcomes, while the potential utility of specifically inhibiting skeletal muscle CPT-1 remains unclear.
“Thus, potent inhibition of liver CPT-1 clearly leads to undesirable outcomes, whereas the potential utility of specifically inhibiting skeletal muscle CPT-1 remains unclear.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMetabolic inflexibility was first introduced in a report showing healthy individuals shift from robust fat oxidation in the fasted state to high glucose oxidation during a hyperinsulinemic-euglycemic clamp, whereas obese and type 2 diabetic subjects show little response.
“This phenomenon, commonly known as “metabolic inflexibility”, was first introduced in a report showing that healthy individuals shift from robust fat oxidation in the fasted state to a high rate of glucose oxidation in response to a hyperinsulinemic-euglycemic clamp (measured by whole body or leg RQ), whereas obese and type 2 diabetic subjects showed little response (Kelley et al., 1999).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kelley et al., 1999
Not checked in the free run.
May combine two claims.
PremisecitationTreating mice with PPARα or PPARβ/δ agonists increases whole-body oxygen consumption without affecting caloric intake, accounting for lower weight gain during high fat feeding.
“Treating mice with PPARα or PPARβ/δ agonists also induces, either directly or indirectly, an increase in whole body oxygen consumption without affecting caloric intake, thus accounting for lower rates of weight gain in response to high fat feeding (Guerre-Millo et al., 2000; Tanaka et al., 2003).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationMice lacking PDH kinase 4 have elevated PDH activity and enhanced glucose tolerance.
“The notion that pyruvate trafficking can indeed impact systemic glucose homeostasis is strengthened by studies in mice lacking PDH kinase 4, which have elevated PDH activity and enhanced glucose tolerance (Jeoung and Harris, 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Jeoung and Harris, 2008
Not checked in the free run.
May combine two claims.
InterpretationcitationPPARα overexpression creates a situation where forced flux through β-oxidation outpaces respiratory demand, and added reducing pressure from high rates of incomplete oxidation interferes with insulin action.
“This implies that PPARα overexpression creates a situation wherein forced flux through β-oxidation outpaces the demand of the respiratory system, and that the added reducing pressure imposed by high rates of incomplete oxidation interferes with insulin action.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationLowering mitochondrial acyl-CoAs, resulting in increased PDH activity and improved metabolic flexibility, can be achieved via dietary L-carnitine supplementation.
“Moreover, recent evidence suggests that lowering of mitochondrial acyl CoAs, resulting in increased PDH activity and improved metabolic flexibility, can be achieved via dietary supplementation with L-carnitine (Noland et al., 2009; Power et al., 2007).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningCrAT opposes the Randle cycle by permitting mitochondrial efflux of excess carbons, thereby facilitating an efficient transition from fat to glucose during the fasted-to-fed transition.
“These results suggest that CrAT opposes the Randle cycle by permitting mitochondrial efflux of excess carbons, which thereby facilitates an efficient transition from fat to glucose during the fasted to fed transition.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn rodents fed a high-fat diet, limitations to muscle glucose uptake reside at the levels of glucose delivery and phosphorylation, as well as GLUT4 transport.
“experiments employing a counter-transport technique concluded that limitations to muscle glucose uptake in rodents fed a high fat diet reside at the levels of glucose delivery and phosphorylation, as well as GLUT4 transport (Wasserman, 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wasserman, 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTXNIP antagonizes glucose uptake through a yet undefined mechanism.
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Parikh et al., 2007 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationMitochondrial-derived ROS modulate insulin signaling.
“mitochondrial-derived ROS modulate insulin signaling (Bloch-Damti and Bashan, 2005; Evans et al., 2005).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationHexokinases I and II can translocate to the mitochondrial outer membrane, where their catalytic activities are less sensitive to product inhibition.
“hexokinases I and II can translocate to the mitochondrial outer membrane where their catalytic activities are less sensitive to product inhibition (Azoulay-Zohar et al., 2004; Hashimoto and Wilson, 2002; John et al., 2011).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationMuscle-specific ablation of CrAT results in blunted switching from fatty acid to glucose substrate at the whole-body level and in isolated mitochondria.
“blunted switching from fatty acid to glucose substrate at the whole body level and in isolated mitochondria”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Muoio et al., (in press)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTXNIP is a redox-regulatory protein belonging to the α-arrestin family.
“thioredoxin interacting protein (TXNIP), a redox-regulatory protein belonging to the α-arrestin family (Chutkow et al., 2010; Hui et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationTXNIP binds to and inhibits thioredoxin.
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Parikh et al., 2007 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningCompetition between oxidative substrates might increase a mitochondrial-localized pool of glucose-6-phosphate that triggers MondoA translocation and transcriptional induction of TXNIP to reduce glucose uptake.
“Thus, competition between oxidative substrates might increase a mitochondrial-localized pool of glucose-6-phosphate that in turn triggers MondoA translocation and transcriptional induction of TXNIP to reduce uptake of unwanted glucose fuel (Figure 1).”
Quote in the paperSubstantial claim- Rests on an assumption: In skeletal muscle, TXNIP gene expression is controlled by MondoA.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSulfur switches have regulatory roles in cell signaling and metabolic control.
“These so-called “sulfur switches” are gaining increasing recognition for their regulatory roles in cell signaling and metabolic control (Hui et al., 2008; Jones, 2008)”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningChronic overabundance of nutrients leads to persistent pressure on the electron transport chain and resultant disruption of redox balance and ROS signaling.
“This sets the stage for a highly plausible scenario wherein chronic overabundance of these nutrients leads to persistent pressure on the ETC and resultant disruption of redox balance and ROS-signaling.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationHeightened flux through FAD-linked enzyme complexes, in the absence of high ATP demand, elevates reducing pressure and increases ROS production.
“heightened flux through the foregoing enzyme complexes, in the absence of high ATP demand (i.e. exercise), is predicted to elevate reducing pressure within the system, particularly the backpressure on complex I, thereby increasing ROS production (reviewed in (Fisher-Wellman and Neufer, (in press)) (Figure 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fisher-Wellman and Neufer, (in press)
Not checked in the free run.
May combine two claims.
PremisecitationIn lean but severely insulin resistant muscle-specific PPARα transgenic mice, administration of the CPT-1 inhibitor oxfenicine blocked fatty acid oxidation and rescued insulin sensitivity, despite inducing profound lipid accumulation in muscle.
“In the lean but severely insulin resistant muscle-specific PPARα transgenic mice, administration of the CPT-1 inhibitor oxfenicine blocked fatty acid oxidation and rescued insulin sensitivity, despite inducing profound lipid accumulation in muscle (Finck et al., 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Finck et al., 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSulfur switches form an intracellular redox circuit linking mitochondrial H2O2 emission to control of redox-sensitive phosphatases that target the insulin signaling pathway.
“have recently been suggested to form an intracellular redox circuit linking mitochondrial H2O2 emission to the control of redox-sensitive phosphatases that target the insulin signaling pathway (reviewed in (Fisher-Wellman and Neufer, (in press))).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fisher-Wellman and Neufer, (in press)
Not checked in the free run.
May combine two claims.
PremisecitationMuscles of Sirt3 knockout mice have increased acetylation of LCAD, SOD2, and several ETC complexes, accompanied by elevated acylcarnitines, TBARS, and pJNK.
“muscles of Sirt3 knockout mice have increased acetylation of LCAD, SOD2 and several ETC complexes, which is accompanied by elevated acylcarnitines, TBARS and pJNK (Jing et al., 2011; Qiu et al., 2010).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSirt3 is an established deacetylase whose targets include LCAD, succinate dehydrogenase, and SOD2.
“Sirt3 is an established deacetylase whose targets include long chain acyl CoA dehydrogenase (LCAD), succinate dehydrogenase and Mn superoxide dismutase (SOD2) (Hirschey et al., 2010; Qiu et al., 2010).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningA unifying mechanism of nutrient-induced insulin resistance seems improbable given the pathophysiological complexities of the disorder.
“Although a unifying mechanism of nutrient-induced insulin resistance seems improbable given the pathophysiological complexities of the disorder”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIncreasing flux through β-oxidation without a corresponding boost in energy demand imposes unwarranted reducing pressure on the respiratory system, which impinges upon redox balance and insulin action.
“increasing flux through β-oxidation without a corresponding boost in energy demand imposes unwarranted reducing pressure on the respiratory system, which in turn impinges upon redox balance and insulin action.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIf flux through β-oxidation increases as a consequence of energy demand, the system operates in metabolic balance and insulin sensitivity is maintained.
“Conversely, if flux through β-oxidation increases as a consequence of energy demand, the system then operates in metabolic balance and insulin sensitivity is maintained.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenThe relative contributions of various stress sensing mechanisms to the origin and progression of insulin resistance likely depend on tissue specificity, diet composition, and genetic predisposition.
“The relative contributions of various stress sensing mechanisms to the origin and progression of insulin resistance is likely to depend on tissue specificity, diet composition and genetic predisposition.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenChronic exposure to adverse metabolic conditions imposes a persistent nutrient burden on most, if not all, subcellular compartments, leading inevitably to cellular distress and dysfunction at multiple levels.
“Chronic exposure to these adverse metabolic conditions imposes a persistent nutrient burden on most, if not all, subcellular compartments, leading inevitably to cellular distress and dysfunction at multiple levels.”
Quote in the paperNot a substantial claim- Rests on an assumption: The recent surge in the prevalence of insulin resistance stems largely from inactivity, caloric excess, and poor nutrient quality of heavily processed foods.
May combine two claims.
InterpretationreasoningMitochondrial ROS production is a common denominator that factors into each of the nutrient stress mechanisms and can be positioned both upstream and downstream of cellular insults.
“one common denominator that factors into each of the foregoing nutrient stress mechanisms is mitochondrial ROS production, which can be positioned both upstream and downstream of the foregoing cellular insults.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCorrection of this imbalance by lowering carbon import, increasing the rate of energy expenditure, or enhancing rates of carbon efflux restored both mitochondrial energetic balance and systemic glucose tolerance.
“correction of this imbalance by one of three disparate strategies (lowering carbon import, increasing the rate of energy expenditure or enhancing rates of carbon efflux) restored both mitochondrial energetic balance and systemic glucose tolerance (Koves et al., 2005; Koves et al., 2008; Noland et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningROS signaling might serve as a critical site of convergence and a potential avenue for nutraceutical and/or pharmaceutical intervention.
“ROS signaling might serve as a critical site of convergence and a potential avenue for nutraceutical and/or pharmaceutical intervention.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Mitochondrial respiration in all cells is governed by energy demand, including basal or idling respiratory activity and ATP regeneration.
“Mitochondrial respiration in all cells is governed by energy demand; i.e., the energy utilized to support the basal or “idling” activity of the respiratory system plus that required for ATP regeneration.”
The paper relies on this without support.
Oxidative phosphorylation is rarely operating at maximal capacity.
“oxidative phosphorylation is rarely operating at maximal capacity”
The paper relies on this without support.
Intracellular lipids accumulate whenever fatty acid supply exceeds cellular energy needs.
“intracellular lipids amass whenever the supply of fatty acids exceeds the energy needs of the cell”
The paper relies on this without support.
Supply must adjust to demand, not the reverse.
“In other words, supply must adjust to demand, not vice versa.”
The paper relies on this without support.
Acylcarnitines are generally viewed as byproducts of mitochondrial metabolism that report on cellular fluctuations in substrate supply and flux limitations at specific catabolic enzymes.
“These metabolites are generally viewed as byproducts of mitochondrial metabolism that report on cellular fluctuations in substrate supply and flux limitations at specific catabolic enzymes.”
The paper relies on this without support.
The genetic approaches used in CPT-1 overexpression studies yield notoriously poor transfection efficiencies.
“the genetic approaches used in these studies yield notoriously poor transfection efficiencies”
The paper relies on this without support.
Acylcarnitines can traverse cellular membranes, unlike their acyl-CoA precursors.
“Unlike their acyl-CoA precursors, acylcarnitines can traverse cellular membranes.”
The paper relies on this without support.
Interconversion of acyl-CoA and acylcarnitines is thought to play a key role in regulating mitochondrial acyl-CoA balance.
“Accordingly, interconversion of these molecules is thought to play a key role in regulating mitochondrial acyl-CoA balance.”
The paper relies on this without support.
In skeletal muscle, TXNIP gene expression is controlled by MondoA.
“In skeletal muscle, TXNIP gene expression is controlled by MondoA”
The paper relies on this without support.
ROS signaling and redox sensing rely heavily on the interdependent glutathione and thioredoxin reducing systems.
“ROS signaling and redox sensing rely heavily on the interdependent glutathione and thioredoxin reducing systems.”
The paper relies on this without support.
The glutathione and thioredoxin systems use the reducing power of NADPH to mitigate oxidative stress and modulate reversible oxidation/reduction of protein thiols/disulfides.
“Both use the reducing power of NADPH to mitigate oxidative stress and to modulate reversible oxidation/reduction of protein thiols/disulfides.”
The paper relies on this without support.
At least 20% of the mitochondrial proteome is acetylated.
“at least 20% of the mitochondrial proteome is acetylated.”
The paper relies on this without support.
Every major pathway of intermediary metabolism is represented among the list of acetylated proteins.
“every major pathway of intermediary metabolism was represented among the list of acetylated proteins.”
The paper relies on this without support.
Sirt3, sirt4, and sirt5 localize to mitochondria.
“three members of the sirtuin family of deacetylases; sirt3, sirt4 and sirt5, which localize to the mitochondria.”
The paper relies on this without support.
Nearly all transgenic mouse models resistant to high-fat diet-induced obesity and insulin resistance have elevated whole-body VO2 with similar or even greater food intake relative to wildtype littermates.
“nearly all of these models have elevated whole-body VO2 with similar or even greater food intake relative their wildtype littermates.”
The paper relies on this without support.
Many of the same genetic manipulations result in activation of AMPK.
“many of the same genetic manipulations resulted in the activation of 5’AMP-activated kinase (AMPK)”
The paper relies on this without support.
Cellular and mitochondrial bioenergetics is governed by the rate of energy expenditure.
“cellular and mitochondrial bioenergetics is governed by the rate of energy expenditure”
The paper relies on this without support.
The recent surge in the prevalence of insulin resistance stems largely from inactivity, caloric excess, and poor nutrient quality of heavily processed foods.
“the recent surge in the prevalence of insulin resistance stems largely from inactivity, caloric excess and the poor nutrient quality of heavily processed foods.”
The paper relies on this without support.
Dietary modification and habitual exercise are undeniably effective in combatting nutrient overload.
“The two therapies that are undeniably effective in combatting nutrient overload include dietary modification and habitual exercise.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Sustained energy surplus raises mitochondrial metabolic by-products that could contribute to the development of insulin resistance and metabolic inflexibility.
“Emergent evidence suggests that a chronic positive energy balance increases by-products of mitochondrial metabolism that may trigger the pathogenesis of insulin resistance and metabolic inflexibility (16,17).”
From Defects in mitochondrial efficiency and H2O2 emissions in obese women are restored to a lean phenotype with aerobic exercise training (2015) · cites this paper as [16]
Prior obesity models suggest that β-oxidation exceeds TCA cycle capacity, causing buildup of acetyl-CoA, acylcarnitine esters, and mtH2O2.
“These data may have important implications, as previous models of obesity have indicated that β-oxidation outpaces TCA cycle, leading to accumulation of acetyl-CoA, acylcarnitine esters, and mtH2O2 (16,45,46).”
From Defects in mitochondrial efficiency and H2O2 emissions in obese women are restored to a lean phenotype with aerobic exercise training (2015) · cites this paper as [16]
This suggests that fatty acid oxidation might already be enhanced during obesity, contributing to the development of insulin resistance.
“This suggests that FAO might already be enhanced during obesity, contributing to the development of insulin resistance ([121](#B121)).”
From Mitochondrial fatty acid oxidation in obesity (2013) · cites this paper as [121]
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · see citing works
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · see citing works
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714 · see citing works
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · see citing works
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321 · see citing works
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · see citing works
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · see citing works
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070 · see citing works
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
Rolfe, D. F., & Brown, G. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.731 · Cited by 2,021 · see citing works
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990 · see citing works
Self-citationPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · see citing works
SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation
Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Biddinger, S., Ilkayeva, O. R., et al. (2010) · Nature · doi:10.1038/nature08778 · Cited by 1,687 · see citing works
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., et al. (2011) · Science · doi:10.1126/science.1207861 · Cited by 1,429 · see citing works
Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation
Qiu, X., Brown, K., Hirschey, M. D., Verdin, E., & Chen, D. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.015 · Cited by 1,310 · see citing works
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253 · see citing works
Self-citationRadical-free biology of oxidative stress
Jones, D. P. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00283.2008 · Cited by 1,213 · see citing works
Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096 · see citing works
Interplay between lipids and branched-chain amino acids in development of insulin resistance
Newgard, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.024 · Cited by 1,080 · see citing works
Identification of lysine succinylation as a new post-translational modification
Zhang, Z., Tan, M., Xie, Z., Dai, L., Chen, Y., & Zhao, Y. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.495 · Cited by 1,027 · see citing works
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017 · see citing works
Inactivation of the Fto gene protects from obesity
Fischer, J., Koch, L., Emmerling, C., Vierkotten, J., Peters, T., Brüning, J. C., & Rüther, U. (2009) · Nature · doi:10.1038/nature07848 · Cited by 943 · see citing works
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. H., & Wakil, S. J. (2001) · Science · doi:10.1126/science.1056843 · Cited by 903 · see citing works
Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat
Smith, S. J., Cases, S., Jensen, D. R., Chen, H. C., Sande, E., Tow, B., Sanan, D. A., Raber, J., Eckel, R. H., & Farese, R. V. (2000) · Nature Genetics · doi:10.1038/75651 · Cited by 895 · see citing works
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887 · see citing works
Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306981100 · Cited by 832 · see citing works
Bonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.-A., Morio, B., Vidal, H., & Rieusset, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32601 · Cited by 819 · see citing works
Hirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M. M., Schwer, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.019 · Cited by 787 · see citing works
The first identification of lysine malonylation substrates and its regulatory enzyme
Peng, C., Lu, Z., Xie, Z., Cheng, Z., Chen, Y., Tan, M., Luo, H., Zhang, Y., He, W., Yang, K., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.012658 · Cited by 751 · see citing works
Mihalik, S. J., Goodpaster, B. H., Kelley, D. E., Chace, D. H., Vockley, J., Toledo, F. G. S., & DeLany, J. P. (2010) · Obesity · doi:10.1038/oby.2009.510 · Cited by 653 · see citing works
Lipid oxidation is reduced in obese human skeletal muscle
Kim, J.-Y., Hickner, R. C., Cortright, R. L., Dohm, G. L., & Houmard, J. A. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1039 · Cited by 634 · see citing works
Guerre-Millo, M., Gervois, P., Raspé, E., Madsen, L., Poulain, P., Derudas, B., Herbert, J.-M., Winegar, D. A., Willson, T. M., Fruchart, J.-C., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.22.16638 · Cited by 605 · see citing works
Adams, S. H., Hoppel, C. L., Lok, K. H., Zhao, L., Wong, S. W., Minkler, P. E., Hwang, D. H., Newman, J. W., & Garvey, W. T. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.103754 · Cited by 598 · see citing works
The Molecular Basis for Oxidative Stress-Induced Insulin Resistance
Evans, J. L., Maddux, B. A., & Goldfine, I. D. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1040 · Cited by 587 · see citing works
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 585 · see citing works
Insulin resistance is a cellular antioxidant defense mechanism
Hoehn, K. L., Salmon, A. B., Hohnen-Behrens, C., Turner, N., Hoy, A. J., Maghzal, G. J., Stocker, R., Van Remmen, H., Kraegen, E. W., Cooney, G. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902380106 · Cited by 540 · see citing works
High-fat diets cause insulin resistance despite an increase in muscle mitochondria
Hancock, C. R., Han, D.-H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., & Holloszy, J. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802057105 · Cited by 538 · cited 2× · see citing works
“In aggregate, the results showed that the early stages of diet-induced insulin resistance are characterized by increasing βoxidation and no change in respiratory capacity (Hancock et al., 2008; Kraegen et al., 2008; Noland et al., 2009).”
BackgroundMetabolic flexibility and insulin resistance
Galgani, J. E., Moro, C., & Ravussin, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90558.2008 · Cited by 532 · cited 1× · see citing works
“One viewpoint suggests that the inability to appropriately activate glucose oxidation in response to a meal simply reflects a secondary consequence of impaired insulin action (Galgani et al., 2008).”
BackgroundExcess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle
Turner, N., Bruce, C. R., Beale, S. M., Hoehn, K. L., So, T., Rolph, M. S., & Cooney, G. J. (2007) · Diabetes · doi:10.2337/db07-0093 · Cited by 520 · see citing works
TXNIP regulates peripheral glucose metabolism in humans
Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040158 · Cited by 495 · see citing works
Diacylglycerol-mediated insulin resistance
Erion, D. M., & Shulman, G. I. (2010) · Nature Medicine · doi:10.1038/nm0410-400 · Cited by 493 · see citing works
Simoneau, J., Veerkamp, J. H., Turcotte, L. P., & Kelley, D. E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2051 · Cited by 491 · see citing works
Jing, E., Emanuelli, B., Hirschey, M. D., Boucher, J., Lee, K. Y., Lombard, D., Verdin, E. M., & Kahn, C. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111308108 · Cited by 469 · see citing works
Koves, T. R., Li, P., An, J., Akimoto, T., Slentz, D., Ilkayeva, O., Dohm, G. L., Yan, Z., Newgard, C. B., & Muoio, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507621200 · Cited by 464 · see citing works
Self-citationAn, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., & Newgard, C. B. (2004) · Nature Medicine · doi:10.1038/nm995 · Cited by 450 · see citing works
Self-citationSimoneau, J.-A., & Kelley, D. E. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.166 · Cited by 441 · see citing works
Huffman, K. M., Shah, S. H., Stevens, R. D., Bain, J. R., Muehlbauer, M., Slentz, C. A., Tanner, C. J., Kuchibhatla, M., Houmard, J. A., Newgard, C. B., et al. (2009) · Diabetes Care · doi:10.2337/dc08-2075 · Cited by 410 · see citing works
AZOULAY-ZOHAR, H., ISRAELSON, A., ABU-HAMAD, S., & SHOSHAN-BARMATZ, V. (2004) · Biochemical Journal · doi:10.1042/bj20031465 · Cited by 408 · see citing works
Abu-Elheiga, L., Oh, W., Kordari, P., & Wakil, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733877100 · Cited by 389 · see citing works
Proposed mechanisms for the induction of insulin resistance by oxidative stress
Bloch-Damti, A., & Bashan, N. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1553 · Cited by 388 · see citing works
Wasserman, D. H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90563.2008 · Cited by 384 · see citing works
Muoio, D. M., Noland, R. C., Kovalik, J.-P., Seiler, S. E., Davies, M. N., DeBalsi, K. L., Ilkayeva, O. R., Stevens, R. D., Kheterpal, I., Zhang, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.005 · Cited by 372 · see citing works
Self-citationBruce, C. R., Hoy, A. J., Turner, N., Watt, M. J., Allen, T. L., Carpenter, K., Cooney, G. J., Febbraio, M. A., & Kraegen, E. W. (2009) · Diabetes · doi:10.2337/db08-1078 · Cited by 363 · see citing works
Simoneau, J., Colberg, S. R., Thaete, F. L., & Kelley, D. E. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781930 · Cited by 362 · cited 2× · see citing works
“…to lean subjects; with the apparent mitochondrial insufficiencies being most pronounced in the severely obese and/or diabetic conditions (Hulver et al., 2003; Kelley et al., 2002; Kim et al., 2000; Noland et al., 2003; Simoneau et al., 1995; Simoneau and Kelley, 1997; Simoneau et al., 1999).”
BackgroundThe Protein Kinase IKKɛ Regulates Energy Balance in Obese Mice
Chiang, S.-H., Bazuine, M., Lumeng, C. N.-K., Geletka, L. M., Mowers, J. C., White, N. M. A., Ma, J.-T., Zhou, J., Qi, N., Westcott, D. J., et al. (2009) · Cell · doi:10.1016/j.cell.2009.06.046 · Cited by 344 · see citing works
Skeletal muscle lipid metabolism with obesity
Hulver, M. W., Berggren, J. R., Cortright, R. N., Dudek, R. W., Thompson, R. P., Pories, W. J., MacDonald, K. G., Cline, G. W., Shulman, G. I., Dohm, G. L., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2002 · Cited by 339 · see citing works
Choi, C. S., Savage, D. B., Abu-Elheiga, L., Liu, Z.-X., Kim, S., Kulkarni, A., Distefano, A., Hwang, Y.-J., Reznick, R. M., Codella, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706794104 · Cited by 325 · see citing works
Lee, H.-Y., Choi, C. S., Birkenfeld, A. L., Alves, T. C., Jornayvaz, F. R., Jurczak, M. J., Zhang, D., Woo, D. K., Shadel, G. S., Ladiges, W., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.004 · Cited by 319 · see citing works
Noland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317 · see citing works
Self-citationLinking mitochondrial bioenergetics to insulin resistance via redox biology
Fisher-Wellman, K. H., & Neufer, P. D. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.12.008 · Cited by 316 · see citing works
Self-citationDobbins, R. L., Szczepaniak, L. S., Bentley, B., Esser, V., Myhill, J., & McGarry, J. D. (2001) · Diabetes · doi:10.2337/diabetes.50.1.123 · Cited by 315 · see citing works
Newsholme, E. A., Randle, P. J., & Manchester, K. L. (1962) · Nature · doi:10.1038/193270a0 · Cited by 295 · see citing works
Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice
Li, B., Nolte, L. A., Ju, J.-S., Ho Han, D., Coleman, T., Holloszy, J. O., & Semenkovich, C. F. (2000) · Nature Medicine · doi:10.1038/80450 · Cited by 291 · see citing works
Stoltzman, C. A., Peterson, C. W., Breen, K. T., Muoio, D. M., Billin, A. N., & Ayer, D. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712199105 · Cited by 283 · see citing works
Self-citationSugden, M. C., & Holness, M. J. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450600935263 · Cited by 281 · see citing works
Choi, C. S., Befroy, D. E., Codella, R., Kim, S., Reznick, R. M., Hwang, Y.-J., Liu, Z.-X., Lee, H.-Y., Distefano, A., Samuel, V. T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810339105 · Cited by 279 · see citing works
Hepatic triacylglycerol accumulation and insulin resistance
Nagle, C. A., Klett, E. L., & Coleman, R. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800053-jlr200 · Cited by 272 · see citing works
Finck, B. N., Bernal-Mizrachi, C., Han, D. H., Coleman, T., Sambandam, N., LaRiviere, L. L., Holloszy, J. O., Semenkovich, C. F., & Kelly, D. P. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.006 · Cited by 270 · see citing works
Butler, A. A., & Kozak, L. P. (2010) · Diabetes · doi:10.2337/db09-1471 · Cited by 263 · see citing works
Randomized Clinical Trials of Weight Loss Maintenance: A Review
Turk, M. W., Yang, K., Hravnak, M., Sereika, S. M., Ewing, L. J., & Burke, L. E. (2009) · Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000317471.58048.32 · Cited by 258 · see citing works
PPAR-α–Null Mice Are Protected From High-Fat Diet–Induced Insulin Resistance
Guerre-Millo, M., Rouault, C., Poulain, P., André, J., Poitout, V., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Reach, G., & Staels, B. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2809 · Cited by 241 · see citing works
Subcellular localization of hexokinases I and II directs the metabolic fate of glucose
John, S., Weiss, J. N., & Ribalet, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017674 · Cited by 239 · see citing works
Huang, J.-Y., Hirschey, M. D., Shimazu, T., Ho, L., & Verdin, E. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.12.021 · Cited by 231 · see citing works
PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice
Tordjman, K. M., Bernal‐Mizrachi, C., Zemany, L., Weng, S., Chu, F., Zhang, F., Leone, T. C., Coleman, T., Kelly, D. P., & Semenkovich, C. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11497 · Cited by 228 · see citing works
Txnip balances metabolic and growth signaling via PTEN disulfide reduction
Hui, S. T. Y., Andres, A. M., Miller, A. K., Spann, N. J., Potter, D. W., Post, N. M., Chen, A. Z., Sachithanantham, S., Jung, D. Y., Kim, J. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800293105 · Cited by 214 · see citing works
Garland, P. B., Newsholme, E. A., & Randle, P. J. (1962) · Nature · doi:10.1038/195381a0 · Cited by 201 · see citing works
Hakimi, P., Yang, J., Casadesús, G., Massillon, D., Tolentino‐Silva, F., Nye, C. K., Cabrera, M. E., Hagen, D., Utter, C. B., Baghdy, Y., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706127200 · Cited by 200 · see citing works
Cadenas, S., Echtay, K. S., Harper, J. A., Jekabsons, M. B., Buckingham, J. A., Grau, E., Abuin, A., Chapman, H., Clapham, J. C., & Brand, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109736200 · Cited by 199 · see citing works
Chomentowski, P., Coen, P. M., Radiková, Z., Goodpaster, B. H., & Toledo, F. G. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0822 · Cited by 163 · see citing works
Jeoung, N. H., & Harris, R. A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00536.2007 · Cited by 162 · see citing works
Henique, C., Mansouri, A., Fumey, G., Lenoir, V., Girard, J., Bouillaud, F., Prip-Buus, C., & Cohen, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.170431 · Cited by 159 · see citing works
Perdomo, G., Commerford, S. R., Richard, A.-M. T., Adams, S. H., Corkey, B. E., O'Doherty, R. M., & Brown, N. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403566200 · Cited by 158 · see citing works
Hoehn, K. L., Turner, N., Swarbrick, M. M., Wilks, D., Preston, E., Phua, Y., Joshi, H., Furler, S. M., Larance, M., Hegarty, B. D., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.008 · Cited by 156 · see citing works
Goodpaster, B. H., & Kelley, D. E. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0086-2 · Cited by 155 · see citing works
Roden, M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803102 · Cited by 149 · see citing works
Chutkow, W. A., Birkenfeld, A. L., Brown, J. D., Lee, H.-Y., Frederick, D. W., Yoshioka, J., Patwari, P., Kursawe, R., Cushman, S. W., Plutzky, J., et al. (2010) · Diabetes · doi:10.2337/db09-1212 · Cited by 142 · see citing works
Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?
Muoio, D. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.11.007 · Cited by 137 · see citing works
Self-citationHenriksen, E. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.002 · Cited by 136 · cited 1× · see citing works
“Treatment of genetically obese/diabetic rodents with antioxidant nutrients has been shown to improve insulin action and glucose homeostasis (Henriksen, 2006; Hoehn et al., 2009; Houstis et al., 2006).”
BackgroundKrämer, D. K., Al-Khalili, L., Perrini, S., Skogsberg, J., Wretenberg, P., Kannisto, K., Wallberg-Henriksson, H., Ehrenborg, E., Zierath, J. R., & Krook, A. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1157 · Cited by 132 · see citing works
van Herpen, N. A., Schrauwen-Hinderling, V. B., Schaart, G., Mensink, R. P., & Schrauwen, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2243 · Cited by 124 · see citing works
Brand, M. D. (1990) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(05)80131-6 · Cited by 115 · see citing works
Carnitine revisited: potential use as adjunctive treatment in diabetes
Power, R. A., Hulver, M. W., Zhang, J. Y., Dubois, J., Marchand, R. M., Ilkayeva, O., Muoio, D. M., & Mynatt, R. L. (2007) · Diabetologia · doi:10.1007/s00125-007-0605-4 · Cited by 113 · cited 3× · see citing works
“[PubMed: 20111019] Mingorance C, Rodriguez-Rodriguez R, Justo ML, Alvarez de Sotomayor M, Herrera MD. Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.”
BackgroundSelf-citationChakraborti, S., & Chakraborti, T. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(98)00014-x · Cited by 110 · see citing works
Gene knockout of Acc2 has little effect on body weight, fat mass, or food intake
Olson, D. P., Pulinilkunnil, T., Cline, G. W., Shulman, G. I., & Lowell, B. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913492107 · Cited by 109 · see citing works
Muscle choline kinase beta defect causes mitochondrial dysfunction and increased mitophagy
Mitsuhashi, S., Hatakeyama, H., Karahashi, M., Koumura, T., Nonaka, I., Hayashi, Y. K., Noguchi, S., Sher, R. B., Nakagawa, Y., Manfredi, G., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr305 · Cited by 95 · see citing works
Coll, T., Álvarez-Guardia, D., Barroso, E., Gómez-Foix, A. M., Palomer, X., Laguna, J. C., & Vázquez-Carrera, M. (2010) · Endocrinology · doi:10.1210/en.2009-1211 · Cited by 90 · see citing works
CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance
Sebastián, D., Herrero, L., Serra, D., Asins, G., & Hegardt, F. G. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00360.2006 · Cited by 89 · see citing works
Citrate and the regulation of adipose-tissue phosphofructokinase
Denton, R., & Pj, R. (1966) · Biochemical Journal · doi:10.1042/bj1000420 · Cited by 89 · see citing works
Mancuso, D. J., Sims, H. F., Yang, K., Kiebish, M. A., Su, X., Jenkins, C. M., Guan, S., Moon, S. H., Pietka, T., Nassir, F., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115766 · Cited by 89 · see citing works
HARPER, J. A., STUART, J. A., JEKABSONS, M. B., ROUSSEL, D., BRINDLE, K. M., DICKINSON, K., JONES, R. B., & BRAND, M. D. (2002) · Biochemical Journal · doi:10.1042/bj3610049 · Cited by 87 · see citing works
Bell, J. A., Reed, M. A., Consitt, L. A., Martin, O. J., Haynie, K. R., Hulver, M. W., Muoio, D. M., & Dohm, G. L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1596 · Cited by 87 · see citing works
Self-citationZhang, D., Christianson, J., Liu, Z., Tian, L., Choi, C. S., Neschen, S., Dong, J., Wood, P. A., & Shulman, G. I. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.012 · Cited by 84 · see citing works
The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling
Desvergne, B., Ijpenberg, A., Devchand, P. R., & Wahli, W. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00182-9 · Cited by 83 · see citing works
Boyle, K. E., Canham, J. P., Consitt, L. A., Zheng, D., Koves, T. R., Gavin, T. P., Holbert, D., Neufer, P. D., Ilkayeva, O., Muoio, D. M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2253 · Cited by 79 · see citing works
Self-citationM<scp>ETABOLIC</scp> L<scp>ESSONS FROM</scp> G<scp>ENETICALLY</scp> L<scp>EAN</scp> M<scp>ICE</scp>
Reitman, M. L. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.010402.102849 · Cited by 75 · see citing works
Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance
Noland, R. C., Woodlief, T., Whitfield, B. R., Manning, S. M., Evans, J. R., Dudek, R. W., Lust, R. M., & Cortright, R. N. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00399.2006 · Cited by 68 · see citing works
Muscle insulin resistance: a case of fat overconsumption, not mitochondrial dysfunction
Kraegen, E. W., Cooney, G. J., & Turner, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803901105 · Cited by 62 · see citing works
Chapter 8 Acetylation of Mitochondrial Proteins
Hirschey, M. D., Shimazu, T., Huang, J., & Verdin, E. (2009) · Methods in Enzymology · doi:10.1016/s0076-6879(09)05008-3 · Cited by 55 · see citing works
Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders
Herrera, M. D., Mingorance, Rodriguez, Justo, M. L., & de Sotomayor (2011) · Vascular Health and Risk Management · doi:10.2147/vhrm.s14356 · Cited by 53 · see citing works
Kovalik, J., Slentz, D. H., Stevens, R. D., Kraus, W. E., Houmard, J. A., Nicoll, J. B., Lea-Currie, Y. R., Everingham, K., Kien, C. L., Buehrer, B. M., et al. (2011) · Diabetes · doi:10.2337/db10-0427 · Cited by 50 · see citing works
Self-citationVickers, A. E. M., Bentley, P., & Fisher, R. L. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.01.021 · Cited by 48 · see citing works
Molero, J. C., Waring, S. G., Cooper, A., Turner, N. A., Laybutt, D. R., Cooney, G. J., & James, D. E. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0312 · Cited by 46 · see citing works
Sloan, E., & Ayer, D. E. (2010) · Genes & Cancer · doi:10.1177/1947601910377489 · Cited by 42 · see citing works
Hübinger, A., Knode, O., Susanto, F., Reinauer, H., & Gries, F. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979072 · Cited by 38 · see citing works
Hypoglycemic effects of a novel fatty acid oxidation inhibitor in rats and monkeys
Deems, R. O., Anderson, R. C., & Foley, J. E. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.2.r524 · Cited by 35 · see citing works
Metabolism in diabetes mellitus
Benedict, F. G., & Joslin, E. P. (1910) · Carnegie Institution of Washington eBooks · doi:10.5962/t.174874 · Cited by 35 · see citing works
Keil, S., Müller, M., Zoller, G., Haschke, G., Schroeter, K., Glien, M., Ruf, S. G., Focken, I., Herling, A. W., & Schmoll, D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101179e · Cited by 27 · see citing works
Turning WAT into BAT gets rid of fat
Chen, H. C., & Farese, R. V. (2001) · Nature Medicine · doi:10.1038/nm1001-1102 · Cited by 26 · see citing works
Noland, R. C., Hickner, R. C., Jimenez‐Liñan, M., Vidal‐Puig, A., Zheng, D., Dohm, G. L., & Cortright, R. N. (2003) · Metabolism · doi:10.1053/meta.2003.50021 · Cited by 23 · see citing works
The longitudinal effect of inhibiting fatty acid oxidation in diabetic rats fed a high fat diet
Barnett, M., Collier, G., & O'Dea, K. (1992) · Hormone and Metabolic Research · doi:10.1055/s-2007-1003335 · Cited by 21 · see citing works
Metabolic profiling of muscle contraction in lean compared with obese rodents
Thyfault, J. P., Cree, M. G., Tapscott, E. B., Bell, J. A., Koves, T. R., Ilkayeva, O., Wolfe, R. R., Dohm, G. L., & Muoio, D. M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00093.2010 · Cited by 21 · see citing works
Self-citationEffects of Metabolic Approach in Diabetic Patients with Coronary Artery Disease
Fragasso, G., Salerno, A., Spoladore, R., Cera, M., Montanaro, C., & Margonato, A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787582093 · Cited by 17 · see citing works
Hashimoto, M., & Wilson, J. E. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2744 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · see citing works
Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988 · see citing works
Metabolites as regulators of insulin sensitivity and metabolism
Yang, Q., Vijayakumar, A., & Kahn, B. B. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0044-8 · Cited by 681 · see citing works
The Origins and Drivers of Insulin Resistance
Johnson, A. M. F., & Olefsky, J. M. (2013) · Cell · doi:10.1016/j.cell.2013.01.041 · Cited by 639 · see citing works
Guo, S. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0327 · Cited by 625 · see citing works
Schooneman, M. G., Vaz, F. M., Houten, S. M., & Soeters, M. R. (2013) · Diabetes · doi:10.2337/db12-0466 · Cited by 616 · see citing works
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535 · see citing works
Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock
Dyar, K. A., Ciciliot, S., Wright, L. E., Biensø, R. S., Tagliazucchi, G. M., Patel, V. R., Forcato, M., Paz, M. I. P., Gudiksen, A., Solagna, F., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.10.005 · Cited by 454 · see citing works
Metabolic Inflexibility: When Mitochondrial Indecision Leads to Metabolic Gridlock
Muoio, D. M. (2014) · Cell · doi:10.1016/j.cell.2014.11.034 · Cited by 438 · see citing works
Self-citationLuzzo, K. M., Wang, Q., Purcell, S. H., Chi, M. M.-Y., Jimenez, P. T., Grindler, N. M., Schedl, T., & Moley, K. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049217 · Cited by 356 · see citing works
Nolan, C. J., & Prentki, M. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827611 · Cited by 292 · see citing works
Skeletal muscle mitochondrial remodeling in exercise and diseases
Gan, Z., Fu, T., Kelly, D. P., & Vega, R. B. (2018) · Cell Research · doi:10.1038/s41422-018-0078-7 · Cited by 287 · see citing works
Skeletal muscle insulin resistance: role of mitochondria and other ROS sources
Di Meo, S., Iossa, S., & Venditti, P. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0598 · Cited by 282 · see citing works
Mitochondrial and cellular mechanisms for managing lipid excess
Aon, M. A., Bhatt, N., & Cortassa, S. C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00282 · Cited by 253 · see citing works
Engin, A. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_8 · Cited by 260 · see citing works
Mitochondrial fatty acid oxidation in obesity
Serra, D., Mera, P., Malandrino, M. I., Mir, J. F., & Herrero, L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4875 · Cited by 246 · see citing works
Lepretti, M., Martucciello, S., Burgos Aceves, M., Putti, R., & Lionetti, L. (2018) · Nutrients · doi:10.3390/nu10030350 · Cited by 232 · see citing works
Nolan, C. J., Ruderman, N. B., Kahn, S. E., Pedersen, O. B., & Prentki, M. (2015) · Diabetes · doi:10.2337/db14-0694 · Cited by 230 · see citing works
Links Between Ectopic Fat and Vascular Disease in Humans
Lim, S. K., & Meigs, J. B. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303035 · Cited by 218 · see citing works
Sylow, L., Jensen, T. E., Kleinert, M., Højlund, K., Kiens, B., Wojtaszewski, J. F. P., Prats, C., Schjerling, P., & Richter, E. A. (2013) · Diabetes · doi:10.2337/db12-1148 · Cited by 210 · see citing works
Towards a multidisciplinary approach to understand and manage obesity and related diseases
Bischoff, S. C., Boirie, Y., Cederholm, T., Chourdakis, M., Cuerda, C., Delzenne, N. M., Deutz, N. E. P., Fouque, D. P., Genton, L., Gil, C., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.11.007 · Cited by 211 · see citing works
Ryan, B. J., Schleh, M. W., Ahn, C., Ludzki, A. C., Gillen, J. B., Varshney, P., Pelt, D. W. V., Pitchford, L. M., Chenevert, T. L., Gioscia‐Ryan, R. A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa345 · Cited by 206 · see citing works
From OCR and ECAR to energy: Perspectives on the design and interpretation of bioenergetics studies
Schmidt, C. A., Fisher‐Wellman, K. H., & Neufer, P. D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101140 · Cited by 197 · see citing works
Self-citationvan Zutphen, T., Čiapaitė, J., Bloks, V. W., Ackereley, C., Gerding, A., Jurdzinski, A., de Moraes, R. A., Zhang, L., Wolters, J. C., Bischoff, R., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.046 · Cited by 190 · see citing works
Role of carnitine and its derivatives in the development and management of type 2 diabetes
Bene, J., Hadzsiev, K., & Melegh, B. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0017-1 · Cited by 188 · see citing works
Muscle and adipose tissue insulin resistance: malady without mechanism?
Fazakerley, D. J., Krycer, J. R., Kearney, A. L., HOCKING, S. L., & James, D. E. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r087510 · Cited by 181 · see citing works
The Effect of n-3 Fatty Acids on Glucose Homeostasis and Insulin Sensitivity
Flachs, P., Rossmeisl, M., & Kopecký, J. (2014) · Physiological Research · doi:10.33549/physiolres.932715 · Cited by 183 · see citing works
Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD
Afshinnia, F., Rajendiran, T. M., Soni, T., Byun, J., Wernisch, S., Sas, K. M., Hawkins, J. J., Bellovich, K. A., Gipson, D., Michailidis, G. C., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017030350 · Cited by 187 · see citing works
The role of mitochondrial sirtuins in health and disease
Osborne, B., Bentley, N. L., Montgomery, M. K., & Turner, N. A. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.197 · Cited by 179 · see citing works
Mitochondria and lipid metabolism in mammalian oocytes and early embryos
Bradley, J. M., & Swann, K. (2019) · The International Journal of Developmental Biology · doi:10.1387/ijdb.180355ks · Cited by 180 · see citing works
Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation
Soeters, M. R., Soeters, P. B., Schooneman, M. G., Houten, S. M., & Romijn, J. A. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00397.2012 · Cited by 177 · see citing works
Methods for Assessing Mitochondrial Function in Diabetes
Perry, C. G. R., Kane, D. A., Lanza, I. R., & Neufer, P. D. (2013) · Diabetes · doi:10.2337/db12-1219 · Cited by 165 · see citing works
Self-citationLipotoxicity in obesity and diabetes-related cardiac dysfunction
Zlobine, I., Gopal, K., & Ussher, J. R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.011 · Cited by 170 · see citing works
The Evolving Understanding of the Contribution of Lipid Metabolism to Diabetic Kidney Disease
Stadler, K., Goldberg, I. J., & Susztak, K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0611-8 · Cited by 165 · see citing works
Namgaladze, D., & Brüne, B. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.002 · Cited by 162 · see citing works
Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues
Makrecka‐Kuka, M., Sevostjanovs, E., Vilks, K., Volska, K., Antone, U., Kuka, J., Makarova, E., Pugovičs, O., Dambrova, M., & Liepinsh, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-17797-x · Cited by 162 · see citing works
Fisher‐Wellman, K. H., Davidson, M. T., Narowski, T. M., Lin, C., Koves, T. R., & Muoio, D. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.091 · Cited by 150 · see citing works
Self-citationDyar, K. A., Hubert, M. J., Mir, A. A., Ciciliot, S., Lutter, D., Greulich, F., Quagliarini, F., Kleinert, M., Fischer, K., Eichmann, T. O., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005886 · Cited by 154 · see citing works
Flachs, P., Rossmeisl, M., Kuda, O., & Kopecký, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.02.003 · Cited by 149 · see citing works
Insulin resistance in type 1 diabetes mellitus
Kaul, K., Apostolopoulou, M., & Roden, M. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.002 · Cited by 150 · see citing works
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
Rausch, V., Sala, V., Penna, F., Porporato, P. E., & Ghigo, A. (2021) · Oncogenesis · doi:10.1038/s41389-020-00288-6 · Cited by 146 · see citing works
Excess of free fatty acids as a cause of metabolic dysfunction in skeletal muscle
TUMOVA, J., ANDEL, M., & TRNKA, J. (2016) · Physiological Research · doi:10.33549/physiolres.932993 · Cited by 143 · see citing works
Mitophagy Directs Muscle-Adipose Crosstalk to Alleviate Dietary Obesity
Fu, T., Xu, Z., Liu, L., Guo, Q., Wu, H., Liang, X., Zhou, D., Xiao, L., Liu, L., Liu, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.127 · Cited by 145 · see citing works
Meng, Z.-X., Li, S., Wang, L., Ko, H. J., Lee, Y., Jung, D. Y., Okutsu, M., Yan, Z., Kim, J. K., & Lin, J. D. (2013) · Nature Medicine · doi:10.1038/nm.3144 · Cited by 146 · see citing works
Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling
Funai, K., Song, H., Li, Y., Lodhi, I. J., Wei, X., Yoshino, J., Coleman, T., & Semenkovich, C. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65726 · Cited by 139 · see citing works
Liu, T. F., Vachharajani, V., Millet, P., Bharadwaj, M. S., Molina, A. J. A., & McCall, C. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566349 · Cited by 141 · see citing works
ROWLANDS, D. S., Page, R., Sukala, W. R., Giri, M., Ghimbovschi, S. D., Hayat, I., Cheema, B. S., Lys, I., Leikis, M. J., Sheard, P., et al. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2014 · Cited by 140 · see citing works
Choi, M., Kim, Y., Kwon, E., Ryoo, J. Y., Kim, S. R., & Jung, U. J. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000100 · Cited by 139 · see citing works
Free Fatty Acids and Skeletal Muscle Insulin Resistance
Rachek, L. I. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00008-9 · Cited by 139 · see citing works
Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome
Cooke, A. A., Connaughton, R. M., Lyons, C. L., McMorrow, A. M., & Roche, H. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.021 · Cited by 136 · see citing works
Weight loss is a critical factor to reduce inflammation
Bianchi, V. E. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.08.007 · Cited by 136 · see citing works
Evolving Concepts of Myocardial Energy Metabolism
Lopaschuk, G. D., & Ussher, J. R. (2016) · Circulation Research · doi:10.1161/circresaha.116.310078 · Cited by 134 · see citing works
Skeletal Muscle Phospholipid Metabolism Regulates Insulin Sensitivity and Contractile Function
Funai, K., Lodhi, I. J., Spears, L. D., Yin, L., Song, H., Klein, S., & Semenkovich, C. F. (2015) · Diabetes · doi:10.2337/db15-0659 · Cited by 130 · see citing works
Impaired mitochondrial fat oxidation induces adaptive remodeling of muscle metabolism
Wicks, S. E., Vandanmagsar, B., Haynie, K. R., Fuller, S. E., Warfel, J. D., Stephens, J. M., Wang, M., Han, X., Zhang, J., Noland, R. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418560112 · Cited by 131 · see citing works
Zheng, L., Linarelli, L. E., Liu, L., Wall, S. S., Greenawald, M. H., Seidel, R. W., Estabrooks, P. A., Almeida, F. A., & Cheng, Z. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0093-1 · Cited by 126 · see citing works
Gamboa, J. L., Roshanravan, B., Towse, T., Keller, C. A., Falck, A. M., Yu, C., Frontera, W. R., Brown, N. J., & Ikizler, T. A. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10320819 · Cited by 136 · see citing works
Fatty acid metabolism and the basis of brown adipose tissue function
Calderón‐Domínguez, M., Mir, J. F., Fucho, R., Weber, M., Serra, D., & Herrero, L. (2015) · Adipocyte · doi:10.1080/21623945.2015.1122857 · Cited by 126 · see citing works
Mitochondrial Deficiency Is Associated With Insulin Resistance
Goodpaster, B. (2013) · Diabetes · doi:10.2337/db12-1612 · Cited by 123 · see citing works
Clamp, L. D., Hume, D. J., Lambert, E. V., & Kroff, J. (2017) · Nutrition and Diabetes · doi:10.1038/nutd.2017.31 · Cited by 123 · see citing works
Taddeo, E. P., Laker, R. C., Breen, D. S., Akhtar, Y., Kenwood, B. M., Liao, J. A., Zhang, M., Fazakerley, D. J., Tomsig, J. L., Harris, T. E., et al. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.003 · Cited by 116 · see citing works
Metabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes
Bakar, M. H. A., Sarmidi, M. R., Cheng, K., Khan, A. A., Suan, C. L., Huri, H. Z., & Yaakob, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00158g · Cited by 117 · see citing works
Caton, P., Richardson, S. J., Kieswich, J. E., Bugliani, M., Holland, M. L., Marchetti, P., Morgan, N. G., Yaqoob, M. M., Holness, M. J., & Sugden, M. C. (2013) · Diabetologia · doi:10.1007/s00125-013-2851-y · Cited by 114 · see citing works
Konopka, A. R., Asante, A., Lanza, I. R., Robinson, M. M., Johnson, M. L., Dalla Man, C., Cobelli, C., Amols, M. H., Irving, B. A., & Nair, K. S. (2015) · Diabetes · doi:10.2337/db14-1701 · Cited by 112 · see citing works
“These data may have important implications, as previous models of obesity have indicated that b-oxidation outpaces TCA cycle, leading to accumulation of acetyl-CoA, acylcarnitine esters, and mtH2O2 (16,45,46).”
BackgroundEpigenetic reprogramming in metabolic disorders: nutritional factors and beyond
Cheng, Z., Zheng, L., & Almeida, F. A. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.004 · Cited by 114 · see citing works
Smith, G. I., Yoshino, J., Kelly, S. C., Reeds, D. N., Okunade, A., Patterson, B. W., Klein, S., & Mittendorfer, B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.047 · Cited by 111 · see citing works
Gustafson, B., & Smith, U. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.812 · Cited by 112 · see citing works
Henstridge, D. C., Whitham, M., & Febbraio, M. A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.08.003 · Cited by 110 · see citing works
Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion
Hong, S., Zhou, W., Fang, B., Lu, W., Loro, E., Damle, M., Ding, G., Jager, J., Zhang, S., Zhang, Y., et al. (2016) · Nature Medicine · doi:10.1038/nm.4245 · Cited by 110 · see citing works
Mechanisms of obesity-induced metabolic and vascular dysfunctions
Caldwell, R. W. (2019) · Frontiers in bioscience · doi:10.2741/4758 · Cited by 112 · see citing works
Wong, C. Y. J., Al‐Salami, H., & Dass, C. R. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13359 · Cited by 112 · see citing works
Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes
Roszczyc-Owsiejczuk, K., & Zabielski, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.635175 · Cited by 112 · see citing works
Hypoglycemic and Hypolipidemic Effects of Glucomannan Extracted from Konjac on Type 2 Diabetic Rats
Chen, H., Nie, Q., Hu, J., Huang, X., Zhang, K., Pan, S., & Nie, S. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01192 · Cited by 107 · see citing works
Friedman, J. E. (2018) · Diabetes · doi:10.2337/dbi17-0011 · Cited by 106 · see citing works
Monaco, C. M. F., Hughes, M. C., Ramos, S. V., Varah, N. E., Lamberz, C., Rahman, F. A., McGlory, C., Tarnopolsky, M. A., Krause, M. P., Laham, R., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4602-6 · Cited by 104 · see citing works
Type 2 diabetes – An autoinflammatory disease driven by metabolic stress
Gonzalez, L. L., Garrie, K., & Turner, M. D. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.034 · Cited by 98 · see citing works
Targeting ceramide metabolism in obesity.
Aburasayn, H., Batran, R. A., & Ussher, J. (2016) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00133.2016 · Cited by 94 · see citing works
Sánchez‐Tapia, M., Aguilar‐López, M., Perez‐Cruz, C., Pichardo‐Ontiveros, E., Wang, M., Donovan, S. M., Tovar, A. R., & Torres, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-05096-4 · Cited by 96 · see citing works
Insulin resistance protects the heart from fuel overload in dysregulated metabolic states
Taegtmeyer, H., Beauloye, C., Harmancey, R., & Hue, L. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00854.2012 · Cited by 95 · see citing works
Mitochondrial alteration in type 2 diabetes and obesity: An epigenetic link
Cheng, Z., & Almeida, F. A. (2014) · Cell Cycle · doi:10.4161/cc.28189 · Cited by 94 · see citing works
Acyl-CoA thioesterase-2 facilitates mitochondrial fatty acid oxidation in the liver
Moffat, C., Bhatia, L., Nguyen, T. T., Lynch, P., Wang, M., Wang, D., Ilkayeva, O., Han, X., Hirschey, M. D., Claypool, S. M., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m046961 · Cited by 88 · see citing works
Hafizi Abu Bakar, M., Kian Kai, C., Wan Hassan, W. N., Sarmidi, M. R., Yaakob, H., & Zaman Huri, H. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2601 · Cited by 91 · see citing works
Putti, R., Migliaccio, V., Sica, R., & Lionetti, L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00426 · Cited by 90 · see citing works
PPARα activation protects against cholestatic liver injury
Zhao, Q., Yang, R., Wang, J., Hu, D., & Li, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-10524-6 · Cited by 90 · see citing works
Huang, T., Zheng, D., Houmard, J. A., Brault, J. J., Hickner, R. C., & Cortright, R. N. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00331.2016 · Cited by 90 · see citing works
G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis
Sharma, G., & Prossnitz, E. R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_20 · Cited by 88 · see citing works
The Mitochondria in Diabetic Heart Failure: From Pathogenesis to Therapeutic Promise
Schilling, J. D. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6294 · Cited by 90 · see citing works
Kulkarni, S. S., Joffraud, M., Boutant, M., Ratajczak, J., Gao, A. W., Maclachlan, C., Hernández‐Álvarez, M. I., Raymond, F., Métairon, S., Descombes, P., et al. (2016) · Diabetes · doi:10.2337/db15-1725 · Cited by 86 · see citing works
Williams, K. J., & Wu, X. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.004 · Cited by 81 · see citing works
Cao, B., Wang, D., Pan, Z., Brietzke, E. M., McIntyre, R. S., Musial, N., Mansur, R. B., Subramanieapillai, M., Zeng, J., Huang, N., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0353-x · Cited by 82 · see citing works
Batran, R. A., Gopal, K., Capozzi, M. E., Chahade, J. J., Saleme, B., Dakhili, S. A. T., Greenwell, A. A., Niu, J., Almutairi, M. G., Byrne, N. J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.017 · Cited by 79 · see citing works
Cortassa, S. C., Sollott, S. J., & Aon, M. A. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005588 · Cited by 76 · see citing works
Maternal obesity reduces oxidative capacity in fetal skeletal muscle of Japanese macaques
McCurdy, C. E., Schenk, S., Hetrick, B., Houck, J. A., Drew, B. G., Kaye, S., Lashbrook, M., Bergman, B. C., Takahashi, D. L., Dean, T. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86612 · Cited by 76 · see citing works
Lipid-mediated muscle insulin resistance: different fat, different pathways?
Ritter, O., Jelenik, T., & Roden, M. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1310-2 · Cited by 74 · see citing works
Matos, M. A. D., Vieira, D. V., Pinhal, K. C., Lopes, J. F., Dias-Peixoto, M. F., Pauli, J. R., Castro Magalhães, F. D., Little, J. P., Rocha-Vieira, E., & Amorim, F. T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01451 · Cited by 75 · see citing works
Selenium Supplementation Alters Hepatic Energy and Fatty Acid Metabolism in Mice
Hu, X. Y., Chandler, J. D., Orr, M. L., Hao, L., Liu, K., Uppal, K., Go, Y., & Jones, D. P. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy036 · Cited by 74 · see citing works
Metabolic Flexibility and Its Impact on Health Outcomes
Palmer, B. F., & Clegg, D. J. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.01.012 · Cited by 77 · see citing works
Secondary muscle pathology and metabolic dysregulation in adults with cerebral palsy
Peterson, M. D., Gordon, P. M., Hurvitz, E. A., & Burant, C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00338.2012 · Cited by 73 · see citing works
Mitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67 · see citing works
Protective Mechanisms of Mitochondria and Heart Function in Diabetes
Aon, M. A., Tocchetti, C. G., Bhatt, N., Paolocci, N., & Cortassa, S. C. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6123 · Cited by 70 · see citing works
The biochemistry and physiology of long-chain dicarboxylic acid metabolism
Ranea‐Robles, P., & Houten, S. M. (2023) · Biochemical Journal · doi:10.1042/bcj20230041 · Cited by 70 · see citing works
- Authors
- Muoio, D. M., & Neufer, P. D.
- Affiliations
- Duke University (US)
- East Carolina University (US)
- Corresponding author
- Muoio, Deborah M.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 15
- Issue
- 5
- Pages
- 595-605
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC3348508
- OpenAlex
- W2032264012
- Cited by
- 343
- References
- 122
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 14 · 2023: 16 · 2022: 9 · 2021: 38 · 2020: 23 · 2019: 20 · 2018: 36 · 2017: 25 · 2016: 34 · 2015: 29 · 2014: 30 · 2013: 31 · 2012: 9
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG028930)
- National Heart, Lung, and Blood Institute (R01 HL101189R01, R01HL101189)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK058398, R01DK073488, DK-073488, R01DK074825, R01DK089312)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Keywords
- mitochondrial stress, lipid metabolism, skeletal muscle insulin sensitivity, insulin resistance, mitochondrial oxidative capacity, fat oxidation, acylcarnitines, mitochondrial hydrogen peroxide, redox signaling, skeletal muscle
- MeSH terms
- Animals, Humans, Insulin, Mitochondria, Mitochondria, Muscle, Oxidative Stress, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review